357 related articles for article (PubMed ID: 34452256)
1. Ruthenium Complexes: An Alternative to Platinum Drugs in Colorectal Cancer Treatment.
Mahmud KM; Niloy MS; Shakil MS; Islam MA
Pharmaceutics; 2021 Aug; 13(8):. PubMed ID: 34452256
[TBL] [Abstract][Full Text] [Related]
2. Ruthenium(II)-Cyclopentadienyl-Derived Complexes as New Emerging Anti-Colorectal Cancer Drugs.
Teixeira-Guedes C; Brás AR; Teixeira RG; Valente A; Preto A
Pharmaceutics; 2022 Jun; 14(6):. PubMed ID: 35745864
[TBL] [Abstract][Full Text] [Related]
3. Anticancer Ruthenium(III) Complexes and Ru(III)-Containing Nanoformulations: An Update on the Mechanism of Action and Biological Activity.
Riccardi C; Musumeci D; Trifuoggi M; Irace C; Paduano L; Montesarchio D
Pharmaceuticals (Basel); 2019 Sep; 12(4):. PubMed ID: 31561546
[TBL] [Abstract][Full Text] [Related]
4. Regorafenib and Ruthenium Complex Combination Inhibit Cancer Cell Growth by Targeting PI3K/AKT/ERK Signalling in Colorectal Cancer Cells.
Sharma D; Rasool F; Bharti M; Vyas KM; Magani SKJ
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614133
[TBL] [Abstract][Full Text] [Related]
5. A Cancer Cell-Selective and Low-Toxic Bifunctional Heterodinuclear Pt(IV)-Ru(II) Anticancer Prodrug.
Ma L; Lin X; Li C; Xu Z; Chan CY; Tse MK; Shi P; Zhu G
Inorg Chem; 2018 Mar; 57(5):2917-2924. PubMed ID: 29436828
[TBL] [Abstract][Full Text] [Related]
6. Disruption of the Microtubule Network and Inhibition of VEGFR2 Phosphorylation by Cytotoxic
Acharya S; Maji M; Chakraborty MP; Bhattacharya I; Das R; Gupta A; Mukherjee A
Inorg Chem; 2021 Mar; 60(5):3418-3430. PubMed ID: 33554592
[TBL] [Abstract][Full Text] [Related]
7. Ru(II) Compounds: Next-Generation Anticancer Metallotherapeutics?
Thota S; Rodrigues DA; Crans DC; Barreiro EJ
J Med Chem; 2018 Jul; 61(14):5805-5821. PubMed ID: 29446940
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in ruthenium and platinum based supramolecular coordination complexes for antitumor therapy.
Zhang X; Liu D; Lv F; Yu B; Shen Y; Cong H
Colloids Surf B Biointerfaces; 2019 Oct; 182():110373. PubMed ID: 31376689
[TBL] [Abstract][Full Text] [Related]
9. Metal complexes as DNA intercalators.
Liu HK; Sadler PJ
Acc Chem Res; 2011 May; 44(5):349-59. PubMed ID: 21446672
[TBL] [Abstract][Full Text] [Related]
10. Ruthenium complexes as anticancer agents.
Kostova I
Curr Med Chem; 2006; 13(9):1085-107. PubMed ID: 16611086
[TBL] [Abstract][Full Text] [Related]
11. Stimuli-responsive platinum and ruthenium complexes for lung cancer therapy.
Zhang C; Kang T; Wang X; Song J; Zhang J; Li G
Front Pharmacol; 2022; 13():1035217. PubMed ID: 36324675
[TBL] [Abstract][Full Text] [Related]
12. Fighting against Drug-Resistant Tumors using a Dual-Responsive Pt(IV)/Ru(II) Bimetallic Polymer.
Zeng X; Wang Y; Han J; Sun W; Butt HJ; Liang XJ; Wu S
Adv Mater; 2020 Oct; 32(43):e2004766. PubMed ID: 32964540
[TBL] [Abstract][Full Text] [Related]
13. Metal-based anticancer chemotherapeutic agents.
Muhammad N; Guo Z
Curr Opin Chem Biol; 2014 Apr; 19():144-53. PubMed ID: 24608084
[TBL] [Abstract][Full Text] [Related]
14. Vanadium, Ruthenium and Copper Compounds: A New Class of Nonplatinum Metallodrugs with Anticancer Activity.
Leon IE; Cadavid-Vargas JF; Di Virgilio AL; Etcheverry SB
Curr Med Chem; 2017; 24(2):112-148. PubMed ID: 27554807
[TBL] [Abstract][Full Text] [Related]
15. Dimetallic Ru(II) arene complexes appended on bis-salicylaldimine induce cancer cell death and suppress invasion via p53-dependent signaling.
Rahman FU; Bhatti MZ; Ali A; Duong HQ; Zhang Y; Ji X; Lin Y; Wang H; Li ZT; Zhang DW
Eur J Med Chem; 2018 Sep; 157():1480-1490. PubMed ID: 30282320
[TBL] [Abstract][Full Text] [Related]
16. Recent developments in ruthenium anticancer drugs.
Levina A; Mitra A; Lay PA
Metallomics; 2009 Nov; 1(6):458-70. PubMed ID: 21305154
[TBL] [Abstract][Full Text] [Related]
17. Probing the antibacterial and anticancer potential of tryptamine based mixed ligand Schiff base Ruthenium(III) complexes.
Malik MA; Raza MK; Dar OA; Amadudin ; Abid M; Wani MY; Al-Bogami AS; Hashmi AA
Bioorg Chem; 2019 Jun; 87():773-782. PubMed ID: 30974300
[TBL] [Abstract][Full Text] [Related]
18. Radiosensitisation of human colorectal cancer cells by ruthenium(II) arene anticancer complexes.
Carter R; Westhorpe A; Romero MJ; Habtemariam A; Gallevo CR; Bark Y; Menezes N; Sadler PJ; Sharma RA
Sci Rep; 2016 Feb; 6():20596. PubMed ID: 26867983
[TBL] [Abstract][Full Text] [Related]
19. Anticancer activity and mechanism of bis-pyrimidine based dimetallic Ru(II)(η
Bhatti MZ; Ali A; Duong HQ; Chen J; Rahman FU
J Inorg Biochem; 2019 May; 194():52-64. PubMed ID: 30831390
[TBL] [Abstract][Full Text] [Related]
20. Monomeric and dimeric coordinatively saturated and substitutionally inert Ru(ii) polypyridyl complexes as anticancer drug candidates.
Notaro A; Gasser G
Chem Soc Rev; 2017 Nov; 46(23):7317-7337. PubMed ID: 29027562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
